Delivery Order SPE2DB22D3501-SPE2DB25FWM01
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,561.16, is for the delivery of 20,000 unit vials of the medical product RECOTHROM. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 1, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,714.81 delivery order is for RECOTHROM 20,000 unit vials and has a firm fixed price. The award has an ultimate completion date of October 31, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award is a Delivery Order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of 20,000 unit vials of RECOTHROM, a medical product, with a ceiling value of $1,136.94 and a completion date of June 5, 2025. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 20,000 units of RECOTHROM, a medical product. The contract is a Delivery Order with a Firm Fixed Price of $3,053.89 and an Ultimate Completion Date of February 10, 2025. The awarding agency is the Defense Logistics Agency (DLA) Troop Support Medical, which is a defense agency. This contract is not associated with a set-aside designation,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,222.80 firm-fixed-price delivery order is for the supply of 20,000 unit vials of RECOTHROM, a medical product, with a performance period ending on March 18, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a $6,851.13 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 20,000 unit vials of the pharmaceutical product RECOTHROM, with a completion date of July 11, 2025. The contract is not set-aside and was awarded on July 10, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $2,544.48, for the supply of RECOTHROM 20,000 UN 1S medical products. The contract has an ultimate completion date of May 21, 2025. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation indicated. This award...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $5,464.97 firm fixed price delivery order from the Defense Logistics Agency (DLA) to supply 20,000 units of Recothrom vials. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania by November 30, 2023. No set-aside designation was applied to this award made under the DLA's open-market procurement procedures. As a prime contractor supporting DLA Troop Support Medical...
- This federal contract award is for the delivery of 20,000 unit vials of RECOTHROM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $13,353 and a completion date of November 5, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed price pricing type. There is no set-aside designation mentioned. Amerisourcebergen Drug...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 20,000 unit vials of the drug RECOTHROM. The award, valued at $15,008.99, is a Delivery Order contract with a Firm Fixed Price pricing type. The contracting agency is the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract has an ultimate completion date of May 11, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWM01Delivery Order
The Defense Logistics Agency awarded a $3,582.76 delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of RECOTHROM under a firm fixed price contract, with an ultimate completion date of July 21, 2025. This is a non-set-aside award issued on July 18, 2025, with performance to be completed in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs supporting military and veteran healthcare systems. The company's extensive portfolio of federal contracts with DLA demonstrates its capability to meet competitive procurement requirements across a wide spectrum of pharmaceutical products and medical supplies. This delivery order for RECOTHROM, a thrombin product commonly used in surgical applications, reflects the company's role in supporting the Defense Health Agency and broader military healthcare operations through flexible contract vehicles that facilitate rapid medical supply delivery.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 7/18/25 |